Clinical trial Recruiting at 1 site Observational Ages 20 to 80

Evaluating heart tissue viability using advanced MRI techniques

Official title: Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

Run by University of Texas Southwestern Medical Center · NCT06047028 · Data updated 2026-11-12

This study is testing a new MRI technique to see if it can help doctors find healthy heart tissue in patients with ischemic cardiomyopathy so they can better decide who needs heart surgery.

Quick facts

Study typeObservational
Ages20 Years to 80 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity of Texas Southwestern Medical Center
Academic / other
Drugs / interventionsradiation
Locations1 site (Dallas, Texas)
StatusRecruiting
StartedJuly 1, 2023
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedSeptember 11, 2026
Trial IDNCT06047028 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 40 to 80 with ischemic cardiomyopathy and a left ventricular ejection fraction (LVEF) of less than 0.35.

Probably not a fit

Patients with diabetes mellitus or those with a healthy heart (LVEF greater than 0.50) may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the prognostic value of hyperpolarized 13C MRI in detecting viable myocardial tissue in patients with ischemic cardiomyopathy. By measuring the bicarbonate-to-lactate ratio, the study seeks to refine patient selection for coronary artery bypass surgery (CABG) and compare results with a control group of healthy subjects. The study also evaluates the safety of HP 13C pyruvate administration and the reproducibility of MRI scans. This innovative approach avoids ionizing radiation and provides critical insights into cardiac function.

Why it matters

Potential benefit: If successful, this study could enhance the precision of diagnosing myocardial viability, leading to better patient outcomes in heart failure management.

How similar studies have gone: While the use of hyperpolarized 13C MRI is innovative, similar imaging techniques have shown promise in other studies, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
The eligibility criteria for this feasibility study are designed to select participants who will provide valuable insights into myocardial metabolism using HP-13C MRI in various contexts related to ischemic heart failure. These criteria aim to ensure that the study population is diverse and representative of the patient groups under investigation.

Inclusion/Exclusion Criteria:

* Age range: 20 to 80 years
* Sex: Random allocation
* Left ventricular ejection fraction (LVEF):
* Preoperative patients with LVEF \< 0.35
* Healthy subjects with LVEF \> 0.50
* Clinical history:
* Previous myocardial infarction (MI): Excluded for healthy subjects, included for preoperative patients.
* Diabetes mellitus: Excluded for all participants.
* Hypertension: Included for all participants
* Mean blood pressure: Systolic \< 140 mm Hg and Diastolic \< 90 mm Hg for all participants
* Mean heart rate: 78 beats/min for all participants
* Current smoker status: Included but will be reported.
* Medication use within 24 hours: Use will be reported.
* Coronary artery bypass surgery history: Excluded for healthy subjects, included for preoperative patients.
* Infarct type and location: Excluded for healthy subjects, included for preoperative patients with various Q-wave infarct types and locations.
* Number of diseased coronary vessels: Excluded for healthy subjects, included for preoperative patients with at least one diseased vessel.
* Additional medical history and clinical data: Variations in data availability are expected based on the practices of referring physicians and will be documented.

Where it's running

  • University of Texas Southwestern Medical Center
    Dallas, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.